Product information

From Health Canada

New search

The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.

Current status:

Marketed

Current status date:

2003-10-14

Original market date: See footnote 1

1994-12-31

Product name:

DALACIN VAGINAL CREAM

Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section .

DIN:

02060604

Product Monograph/Veterinary Labelling:

Date: 2018-12-21 Product monograph/Veterinary Labelling (PDF version ~ 175K)

Company: 

PFIZER CANADA ULC
17300 Trans-Canada Highway
Kirkland
Quebec
Canada  H9J 2M5

Class: 

Human

Dosage form(s):

Cream

Route(s) of administration:

Vaginal

Number of active ingredient(s):

1

Schedule(s):

Prescription  

Biosimilar Biologic Drug:

No

American Hospital Formulary Service (AHFS): See footnote 3

84:04.04   ANTIBIOTICS

Anatomical Therapeutic Chemical (ATC): See footnote 4

G01AA10  CLINDAMYCIN

Active ingredient group (AIG) number:See footnote 5

0105830001

List of active ingredient(s)
Active ingredient(s) Strength
CLINDAMYCIN (CLINDAMYCIN PHOSPHATE) 20 MG / G

Application information

Related information

Contact us

Version 3.8.0
Date modified: